Avenue Therapeutics Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain. The company's primary objective is to establish IV Tramadol as an invaluable part of a treating physician's repertoire of available pharmaceutical options for the management of postoperative pain.